CervoMed Inc.
CRVO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $323 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $323 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $6,040 | $5,109 | $4,838 | $7,087 |
| G&A Expenses | $2,326 | $3,265 | $2,383 | $2,316 |
| SG&A Expenses | $2,326 | $3,265 | $2,383 | $2,316 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$1,758 | -$1,917 | -$2,162 |
| Operating Expenses | $8,367 | $6,616 | $5,303 | $7,241 |
| Operating Income | -$8,044 | -$6,616 | -$5,303 | -$7,241 |
| % Margin | -2,493.8% | – | – | – |
| Other Income/Exp. Net | $318 | $358 | $409 | $535 |
| Pre-Tax Income | -$7,727 | -$6,258 | -$4,894 | -$6,706 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7,727 | -$6,258 | -$4,894 | -$6,706 |
| % Margin | -2,395.3% | – | – | – |
| EPS | -0.84 | -0.7 | -0.56 | -0.77 |
| % Growth | -20% | -25% | 27.3% | – |
| EPS Diluted | -0.84 | -0.7 | -0.56 | -0.77 |
| Weighted Avg Shares Out | 9,253 | 8,951 | 8,703 | 8,703 |
| Weighted Avg Shares Out Dil | 9,253 | 8,951 | 8,703 | 8,703 |
| Supplemental Information | – | – | – | – |
| Interest Income | $319 | $368 | $409 | $532 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$0 | $0 | $0 | $0 |
| EBITDA | -$7,727 | -$6,616 | -$5,303 | -$7,241 |
| % Margin | -2,395.3% | – | – | – |